Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ZyVersa Therapeutics, Inc. - Common Stock
(NQ:
ZVSA
)
2.880
+0.200 (+7.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ZyVersa Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 26, 2023
Via
Benzinga
Why Is Bed Bath & Beyond (BBBY) Stock Down 24% Today?
April 26, 2023
Bed Bath & Beyond (BBBY) stock is falling on Wednesday as the company's recent bankruptcy announcement weighs on its shares.
Via
InvestorPlace
Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today?
April 26, 2023
ZyVersa Therapeutics (ZVSA) stock is sliding lower on Wednesday following a couple of announcements from the biopharmaceutical company.
Via
InvestorPlace
Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
April 26, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 26, 2023
It's time for another dive into the biggest pre-market stock movers that investors need to know about on Wednesday morning!
Via
InvestorPlace
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?
March 23, 2023
ZyVersa Therapeutics (ZVSA) stock is taking off on Thursday morning without any recent news from the biopharmaceutical company.
Via
InvestorPlace
ZyVersa Therapeutics Announces Publication of an Article in the Journal of Neuroinflammation Addressing the Role of ASC Specks in Propagation of Alpha-Synuclein Pathology in Parkinson’s Disease
April 25, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
ZyVersa Therapeutics Adds Dr. Douglas Golenbock to Its Inflammatory Disease Scientific Advisory Board to Support Advancement of Inflammasome ASC Inhibitor IC 100
April 24, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via
Benzinga
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
April 24, 2023
Via
ACCESSWIRE
Why Bed Bath & Beyond Shares Are Trading Lower By Around 38%; Here Are 20 Stocks Moving Premarket
April 24, 2023
Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) gained 118% to $3.64 in pre-market trading after declining around 5% on Friday. ZyVersa Therapeutics recently posted a wider FY loss.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 24, 2023
We're starting off the week with the biggest pre-market stock movers that traders will want to keep an eye on for Monday morning!
Via
InvestorPlace
ZyVersa: This Drug Maker Is Targeting Critical Diseases With Novel Approaches
April 20, 2023
Steve Glover, Co-Founder, Chairman, CEO, & President of ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA), was recently a guest on Benzinga’s All-Access.
Via
Benzinga
ZyVersa Therapeutics Announces Article Published in Biomaterials Addressing the Critical Role of Inflammasome Activation in Neuroinflammation Resulting from Intracortical Implants
April 19, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics Announces Review Article Published in Frontiers in Pharmacology Addressing Microglial Inflammatory Activity as a Pharmacological Target in Mild Cognitive Impairment and Alzheimer’s Disease
April 13, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics’ CEO, Stephen C. Glover to Appear on Benzinga 'All Access'
April 12, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
April 12, 2023
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 12, 2023
Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.
Via
InvestorPlace
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Planet MicroCap Showcase
April 11, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics Announces Article Published in Brain Pathology Addressing Inflammasome Signaling Proteins in Alzheimer’s Disease
April 10, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
ZyVersa Therapeutics Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
April 03, 2023
From
ZyVersa Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
Via
Benzinga
Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?
March 23, 2023
Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.
Via
InvestorPlace
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 23, 2023
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 23, 2023
Via
Benzinga
Why Is Coinbase (COIN) Stock Down 15% Today?
March 23, 2023
Coinbase Global (COIN) stock is falling on Thursday after the SEC threatened to investigate the crypto exchange's business.
Via
InvestorPlace
Why Is Advent Technologies (ADN) Stock Up 32% Today?
March 23, 2023
Advent Technologies (ADN) stock is climbing higher on Thursday following news of a fuel cell agreement with Hyundai (HYMTF).
Via
InvestorPlace
Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
March 23, 2023
Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 23, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.